August 2019 Price Concessions – 1st update

THIS CONTENT HAS NOW EXPIRED

August 2019 Price Concessions – 1st update

August 16, 2019

Department of Health and Social Care (DHSC) has today granted the following initial list of price concessions:

Drug Pack size Price Concession
Betahistine 16mg tablets 84 £2.99
Cyclizine 50mg/1ml solution for injection ampoules 5 £15.93
Escitalopram 20mg tablets 28 £5.00
Escitalopram 5mg tablets 28 £3.25
Metoprolol 100mg tablets 28 £3.40
Metoprolol 50mg tablets 28 £4.85
Mometasone 50micrograms/dose nasal spray 140 £4.49
Montelukast 10mg tablets 28 £4.38
Pizotifen 1.5mg tablets 28 £4.99
Prednisolone sodium phosphate 0.5% ear/eye drops 10ml £2.50
Tamoxifen 20mg tablets 30 £3.75
Tolbutamide 500mg tablets 28 £16.53

No additional endorsements are required for price concessions. A price concession only applies for the month in which it is granted.

PSNC is still working with the DHSC to agree further concessionary prices on other drugs reported to be unavailable at the stated August 2019 Drug Tariff price. Contractors will be alerted to further updates to the price concession list through our website and via our e-news email.  If you wish to subscribe to our email list, you can receive an email as soon as any announcements are made. Please note that PSNC cannot provide details of any generic products awaiting price concession approval from DHSC.

If you have problems obtaining a Part VIII product or problems obtaining the product at the stated Drug Tariff price, please report the issue to PSNC using the online feedback form on the PSNC Website.
Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. PSNC will investigate the extent of the problem and if appropriate discuss the issue with DHSC.



Posted in: ,


More Latest News >

CPCS webinar now on-demand

Community pharmacy contractors can now access an online recording of our webinar about the new NHS Community Pharmacist Consultation Service...